Top Markets
Coin of the day
Aeterna Zentaris Inc. Aeterna Zentaris Inc.

Aeterna Zentaris Inc.

AEZS
Rank in Stocks #35469
Aeterna Zentaris Inc. operates as a specialized biopharmaceutical company,... Aeterna Zentaris Inc. operates as a specialized biopharmaceutical company, dedicated to the creation and market introduction of both therapeutic drugs and diagnostic tests. Its flagship product, macimorelin, is an orally administered peptidomimetic ghrelin receptor (GHSR-1a) agonist. This compound functions by binding to the GHSR-1a, thereby stimulating the secretion of growth hormone. Macimorelin is employed for diagnosing growth hormone deficiency in both adult and pediatric patients, and is also under investigation for various oncology indications. The drug is marketed commercially under the brand name Macrilen. The company engages in various licensing agreements, prominently with University Wuerzburg. This collaboration encompasses the research, development, manufacture, and commercialization of a prospective COVID-19 vaccine. It also involves developing, producing, and marketing a treatment for neuromyelitis optica spectrum disorder (NMOSD), establishing human 3D intestinal tissue models for infection biology research, and advancing pre-clinical work towards a potential Parkinson's disease therapy. Additionally, Aeterna Zentaris has formed licensing partnerships with Consilient Health Ltd., Novo Nordisk Health Care AG, and NK MEDITECH Ltd. for the development and commercialization of macimorelin in the United States and Canada. Another key collaboration is with The University of Sheffield in the United Kingdom, dedicated to the research, development, manufacturing, and commercialization of parathyroid hormone fusion polypeptides designed to treat primary hypoparathyroidism. Founded in 1990, Aeterna Zentaris Inc. maintains its corporate headquarters in Summerville, South Carolina.
Share Price
$3.97
Last synced: 2024-09-03
Market Cap
$3.86M
Change (1 day)
-1.00%
Change (1 year)
0.00%
Country
US
Trade Aeterna Zentaris Inc. (AEZS)

Category

Stock price history for Aeterna Zentaris Inc. (AEZS)
Highest end of day price: $3.97 on 2024-09-01

Lowest end of day price: $575.50K on 2000-05-01
Stock price history of Aeterna Zentaris Inc. from 2000 to 2026
Annual Stock Price Performance
Year Performance
2024 -51.86%
2023 -40.64%
2022 -66.49%
2021 4.01%
2020 -52.29%
2019 -72.96%
2018 39.23%
2017 -40.47%
2016 -34.47%
2015 -90.98%
2014 -48.12%
2013 -45.55%
2012 -76.97%
2011 -2.05%
2010 86.69%
2009 88.02%
2008 -71.62%
2007 -69.58%
2006 12.35%
2005 -22.65%
2004 108.37%
2003 -16.27%
2002 -37.27%
2001 -17.24%
2000 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE